Objective: To determine the incidence of and risk factors for development of celiac disease (CD) in individuals with type 1 diabetes.
| Study cohort
The study cohort consisted of patients who were diagnosed with diabetes between 1 and 35 years of age. We included only diagnoses of diabetes after the first 90 days of patient registration with the participating practice (incident diabetes) in order to minimize the possibility of misclassification bias from retroactively recorded historical diagnoses 22 and to allow for time-to-event analysis. We included all individuals who had at least one specific Read code consistent with type 1 diabetes. We also included individuals who had at least one non-type-specific diabetes code (Table S1A ) and a prescription for insulin in the year following the first diabetes code but no prescription for oral or other injectable hypoglycemic medications in the year following the first diabetes code (medication codes in Table S1B ). Individuals with non-type-specific diabetes codes and other Read codes for type 2 diabetes, gestational diabetes, neonatal diabetes, maturity onset diabetes of the young (MODY), cystic fibrosis-related diabetes, or steroid-induced diabetes were excluded. We excluded individuals who were 35 years or older at the time of diabetes diagnosis to reduce misclassification bias when using non-type-specific diabetes codes. 23 To minimize misclassification of neonatal (monogenic) diabetes as autoimmune type 1 diabetes, we excluded individuals less than 1 year of age at first diabetes code. We excluded individuals whose birth, registration, or death or transfer dates were out of sequence (eg, birth date after registration date). No diabetes-related serology is available in the dataset.
| Follow-up
Follow-up for CD-free survival began at the date of the first diabetes
Read code (index date). The endpoint was CD diagnosis, and individuals were censored if they transferred out of their practice or died, or the practice stopped collecting data.
| Primary outcome
The primary outcome of interest was incident diagnosis of CD. Incident CD was defined as at least one Read code consistent with CD (Coeliac disease J690.00, Coeliac disease NOS 690z00, Coeliac disease autoantibody profile positive 68W4.00, Gluten enteropathy J690.13, and Dietary advice for coeliac disease ZC2C200) occurring at least 1 day after diabetes diagnosis date. Although CD serology values (eg, tissue transglutaminase, antiendomysial antibody, and antigliadin) are not included in the database, THIN has been used to study pediatric and adult CD, [24] [25] [26] and the use of Read codes for CD diagnosis was previously validated. 27 
| Covariates
Age at diabetes diagnosis and sex were of primary interest as covariates in the Cox regression models. Additional covariates included other conditions of autoimmunity associated with diabetes, including hypothyroidism, hyperthyroidism, and adrenal insufficiency; these were included as time-varying covariates. These conditions were identified by Read code (Table S1A) . Year of diabetes diagnosis was analyzed to adjust for secular trends in CD incidence. Body mass index and hemoglobin A1c were also obtained for descriptive analyses but
were not included in the Cox regression because of high rates of missingness.
| Statistical analysis
For descriptive statistics, categorical variables were reported as proportions, and continuous variables were summarized using median and interquartile range (IQR) because the variables assessed were not normally distributed. Time-to-event analysis using Cox proportional hazards models was performed to evaluate potential risk factors for CD diagnosis. All covariates of interest were included in the initial multivariable Cox regression model and sequentially eliminated until only covariates with P-value <0.05 remained (backward elimination).
The proportional hazards assumption was tested using Schoenfeld residuals and graphically using log-log plots. Kaplan-Meier curves were generated for CD-free survival, and differences in CD-free survival by sex and age at diabetes diagnosis were compared via the logrank test.
Analyses were performed using 
| Sensitivity analyses
To investigate the possibility of bias related to misclassification of diabetes diagnosis, a sensitivity analysis was performed in which we 3 | RESULTS
| Cohort characteristics
We identified 9228 individuals younger than 35 years of age at the time of diabetes diagnosis; 45 (0.5%) individuals had a prior diagnosis of CD, and 3 were diagnosed with both CD and diabetes on the same Kaplan-Meier curves representing CD-free survival over time are depicted in Figure 1 , including CD-free survival distribution for the overall cohort ( Figure 1A ). CD-free survival was significantly lower for females ( Figure 1B , P < 0.001 by log-rank test) and individuals who were younger at the time of diabetes diagnosis ( Figure 1C , P = 0.001 by log-rank test for age categories of 1 to 10, 10 to 15, 15 to 20, and 20 to 35 years). Figure 1D demonstrates the difference in CD-free survival across combined age-and sex-categories, depicting distributions for the youngest (<10 years) and oldest (>20 years) individuals at diabetes diagnosis (P < 0.0001 by log-rank test).
| Factors associated with increased hazard of CD
In multivariable Cox regression, sex, age at diabetes diagnosis, year of diabetes diagnosis, and adrenal insufficiency remained significantly associated with CD (P < 0.05) and were included in the final model.
Thyroid disease was eliminated from the model due to lack of significance (hazard ratio [HR] 1.36, 95% CI 0.69-2.68, P = 0.38). Age of diabetes diagnosis violated the proportional hazards assumption.
Because of significant interactions between age and sex, we stratified our analysis by childhood-onset (<18 years, n = 4558) vs adult-onset (≥18 years, n = 4622) diabetes. Using the clinically-relevant age threshold of 18 years, the proportional hazards assumption was no longer violated within strata.
Adjusted for year of diabetes diagnosis, the impact of age at diagnosis and sex differed by strata, as shown by the adjusted HRs in 
| Sensitivity analyses
To test the strength of associations found in the main multivariable Cox regression analysis, the cohort was restricted to only individuals with diabetes-specific Read codes. This reduced the size of the cohort to 8293 with 192 cases of CD, but strength and significance of each association was nearly identical (Table S2 ). To minimize the potential for misclassification of the outcome, individuals with the Read code "Coeliac disease autoantibody profile positive 68W4.00" as the only CD-related Read code were included as non-CD cases, limiting the CD cases to 188. Again, the strength and significance of each association was nearly identical (Table S3) . Finally, to allow for a more consistent disease definition of CD, we limited the analysis to 2005 to 2015 only. The overall incidence (48.9 per 10 000 person-years, 95% CI 39.4-59.9) was higher than that for the original cohort, but the greater (Table S4 ).
| DISCUSSION
This large, population-based cohort study of children and young adults found that risk of CD among patients with diabetes is significantly greater for those diagnosed with diabetes at younger ages, independent of sex or time period of diagnosis. In addition, we demonstrate a greater hazard of CD in women, but only for those with diabetes diagnosed in young adulthood. Incidence of CD in our cohort was more than 20-fold greater than among the general UK population in the same time period (0.5-1.9 per 10 000 person-years), 24 which is evidence in support of screening in this high-risk population.
Our finding that 25% of individuals were diagnosed with CD more than 5 years after diabetes diagnosis suggests the potential value of prolonged routine screening for the highest-risk individuals (those diagnosed in early childhood). Routine screening of asymptomatic children may be especially valuable given the negative impact of untreated CD on bone mineral density and the critical period of bone accrual during childhood. Our finding of increased risk of CD with younger-onset diabetes is in agreement with previous studies of children with diabetes. 2, 12, 13, 15 The mechanism underlying increased risk of CD with younger age at diabetes diagnosis may be related to the hypothesis of common determinants for both diseases, 13 including environmental exposures, genetic background (including HLA and non-HLA variants), 31, 32 and the gut microbiome. 33 Combined exposure history and genetic predisposition may impact autoimmunity: for example, timing of cereal introduction to infants genetically susceptible to diabetes or CD is associated with seropositivity, and certain viral infections have been linked to diabetes and CD risk. 33 To explore the hypothesis of common determinants of autoimmune disease, we evaluated the impact of autoimmune thyroid disease and adrenal insufficiency on CD diagnosis over time. Although thyroid disease was not associated with greater hazard of CD, this finding likely reflects the overall high prevalence of thyroid disease in individuals with diabetes. 34, 35 Our finding of increased risk of CD after diagnosis of adrenal insufficiency is clinically plausible, but the precision around our estimate was limited due to the rarity of the diagnosis. Our finding of increased risk of CD diagnosis in adult females aligns with the sex differences in CD incidence in the general population. 25 The differential impact of sex with age at diabetes diagnosis may be related to differences in sex hormone exposure with age. Alternatively, the overall greater risk of CD in childhood may outweigh any sex-specific effects that are detectable in the adult population.
Our study has several strengths, including the large cohort of both children and young adults with diabetes that is population-based, increasing the generalizability of our findings. Previous studies assessing CD risk in children with diabetes have had limited to no followup into adulthood. 2, 11, 13, 15, 36 An additional strength of our study was our use of time-to-event analysis to assess the impact of both age at diabetes diagnosis and duration of disease. This analysis allows for an improved understanding of potential risk factors while adjusting for FIGURE 1 Kaplan-Meier curves of celiac disease (CD)-free survival over 10 years of follow-up, depicting overall cohort (A) and stratified by (B) sex, (C) age at diabetes diagnosis, and (D) both sex and age at diabetes diagnosis. Survival distributions differed significantly across strata in each analysis (P < 0.05 by log-rank test) Abbreviations: CI, confidence interval; HR, hazard ratio. *P < 0.01 time-varying covariates and accounting for secular trends in CD diag-However, these screening data are often only available in institutional cohorts, and these studies would not benefit from the large sample size and power available in this study. Finally, our conclusions are limited to the United Kingdom because of the recognized geographical and ethnic variation in incidence and prevalence of CD. 15, 40 In summary, we found that younger age at diabetes independently increased the risk of incident CD in this cohort of both children and adults with diabetes, even after adjusting for time period of diagnosis to account for increasing incidence with time. Female sex was associated with an increased hazard of CD only for those diagnosed with diabetes in young adulthood. Our novel finding that 25% of individuals were diagnosed with CD greater than 5 years from diabetes diagnosis, coupled with the recognition of the difference in risk by age and sex, suggests that a more individualized approach to screening may be warranted. Specifically, regular screening beyond the first 5 years of diagnosis may be warranted for individuals diagnosed in early childhood.
